Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study

Helen A. Fletcher,Ali Filali-Mouhim,Elisa Nemes,Anthony Hawkridge,Alana Keyser,Samuel Njikan,Mark Hatherill,Thomas J. Scriba,Brian Abel,Benjamin M. Kagina,Ashley Veldsman,Nancy Agudelo,Gilla Kaplan,Gregory Hussey,Rafick Pierre Sekaly,Willem A. Hanekom

Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study

2016

Helen A. Fletcher
Ali Filali-Mouhim
Elisa Nemes
Anthony Hawkridge
Alana Keyser
Samuel Njikan
Mark Hatherill
Thomas J. Scriba
Brian Abel
Benjamin M. Kagina
Ashley Veldsman
Nancy Agudelo
Gilla Kaplan
Gregory Hussey
Rafick Pierre Sekaly
Willem A. Hanekom

Background An incomplete understanding of the immunological mechanisms underlying protection against tuberculosis (TB) hampers the development of new vaccines against TB. We aimed to define host correlates of prospective risk of TB disease following bacille Calmette–Guerin (BCG) vaccination.

Keywords:

Prospective cohort study
Case-control study
Bacille Calmette Guerin
Vaccination
Disease
BCG vaccine
Immunology
Tuberculosis
Diabetes mellitus
Medicine
Virology
Mycobacterium bovis
Myeloid

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations